Open Orphan (ORPH)

Sector:

Health Care

Index:

FTSE AIM All-Share

 6.03p
   
  • Change Today:
      0.000p
  • 52 Week High: 8.00p
  • 52 Week Low: 2.55p
  • Currency: UK Pounds
  • Shares Issued: 533.05m
  • Volume: 2,287,751
  • Market Cap: £32.12m
  • RiskGrade: 275

Latest ShareCast News

Open Orphan raising at least ?5m for merger with hVIVO

By Josh White

Date: Friday 31 Jan 2020

(Sharecast News) - Pharmaceutical services company Open Orphan announced a fundraising to raise a minimum of £5m before expenses via a conditional placing of new ordinary shares on Friday, at a price of 6.1p each, to institutional and other investors.

Open Orphan inks three-year contract with mystery European firm

By Iain Gilbert

Date: Monday 06 Jan 2020

(Sharecast News) - Drug consulting services platform Open Orphan has won a new three-year contract with an unnamed German pharmaceutical company.

Open Orphan signs deal with US biopharmaceutical firm SFA

By Josh White

Date: Wednesday 18 Dec 2019

(Sharecast News) - Europe-focussed rare and orphan drug consulting service provider Open Orphan announced the signing of a contract with SFA Therapeutics, a biopharmaceutical company based in Pennsylvania, on Wednesday.

Open Orphan agrees acquisition of hVIVO at 34% p... 09-Dec-2019 ShareCast
Open Orphan signs pharmacology trial contract wi... 18-Nov-2019 ShareCast
Open Orphan inks preferred partner deal with Ips... 11-Nov-2019 ShareCast
Open Orphan signs deal with Empiric Logic to com... 15-Oct-2019 ShareCast
Venn Life Sciences finds 'model client' in Carri... 18-Jan-2019 ShareCast
Venn Life Sciences shuffles board, partners with... 11-Dec-2018 ShareCast
Venn Life Sciences trades in line as it looks to... 15-Feb-2018 ShareCast
Venn Life Sciences revenues edge higher 20-Jul-2017 ShareCast
Venn Life Sciences' share surge after upbeat FY ... 03-Mar-2017 ShareCast
Venn Life Sciences completes £4.74m Innovenn sale 18-Nov-2016 ShareCast
Venn Life Sciences wins new contract worth EUR2.5m 08-Nov-2016 ShareCast
Director dealings: Venn Life Sciences chairman s... 02-Nov-2016 ShareCast
Venn Life Sciences shareholders approve sale of ... 27-Oct-2016 ShareCast
Venn Life Sciences to offload Innovenn UK 04-Oct-2016 ShareCast
Venn Life Sciences shares drop despite revenue r... 28-Sep-2016 ShareCast
Venn Life Sciences wins €2.8m contract 03-Aug-2016 ShareCast
Venn Life Sciences expecting revenues to double 08-Jan-2016 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Open Orphan Market Data

Currency UK Pounds
Share Price 6.03p
Change Today 0.000p
% Change 0.00 %
52 Week High 8.00p
52 Week Low 2.55p
Volume 2,287,751
Shares Issued 533.05m
Market Cap £32.12m
RiskGrade 275

Open Orphan Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
12.76% above the market average12.76% above the market average12.76% above the market average12.76% above the market average12.76% above the market average
2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average
Income Not Available
Growth
38.93% below the market average38.93% below the market average38.93% below the market average38.93% below the market average38.93% below the market average
48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average

Open Orphan Dividends

No dividends found

Trades for 24-Feb-2020

Time Volume / Share Price
16:01 250,000 @ 6.00p
16:00 250,000 @ 5.96p
16:06 166,589 @ 6.00p
16:19 12,400 @ 6.00p
16:11 83,264 @ 6.01p

Open Orphan Key Personnel

CEO Trevor Phillips
COO Tim Sharpington
CFO Leo Toole

Top of Page